REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical CoAnnouncement

20/07/2018 09:15

RNS Number : 2893V
Societe Generale SA
20 July 2018
 


FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 




(a) Full name of discloser:


Société Générale S.A.




(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


 
 
 




(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical CO LTD




(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:








(e) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


19/07/2018




(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES: Shire PLC
 




 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 




Class of relevant security:
 


Ordinary




 
 


Interests


Short positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


2,413,014


0.31


6,933,705


0.88




(2) Cash-settled derivatives:
 


4,106,022


0.52


5,026


0.00




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


121,500


0.02


0


0.00




 
     TOTAL:


6,640,536


0.85


6,938,731


0.88




           
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 




Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:








 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales




Class of relevant security


Purchase/sale


Number of securities


Price per unit
JPY




Ordinary


Purchase


12,900


4734




Ordinary


Purchase


500


4734




Ordinary


Purchase


600


4734




Ordinary


Purchase


1,000


4749




Ordinary


Purchase


300


4780




Ordinary


Purchase


1,000


4767




Ordinary


Purchase


1,000


4767




Ordinary


Purchase


800


4768




Ordinary


Purchase


500


4751




Ordinary


Purchase


1,000


4775




Ordinary


Purchase


200


4753




Ordinary


Purchase


600


4755




Ordinary


Purchase


1,000


4749




Ordinary


Purchase


800


4754




Ordinary


Purchase


500


4787




Ordinary


Purchase


2,000


4751




Ordinary


Purchase


1,000


4755




Ordinary


Purchase


1,000


4756




Ordinary


Purchase


1,000


4754




Ordinary


Purchase


500


4752




Ordinary


Purchase


300


4770




Ordinary


Purchase


100


4752




Ordinary


Purchase


1,000


4752




Ordinary


Purchase


800


4751




Ordinary


Purchase


300


4747




Ordinary


Purchase


800


4770




Ordinary


Purchase


700


4740




Ordinary


Purchase


1,000


4744




Ordinary


Purchase


2,200


4740




Ordinary


Purchase


1,900


4734




Ordinary


Purchase


1,400


4767




Ordinary


Purchase


400


4757




Ordinary


Purchase


1,100


4751




Ordinary


Purchase


300


4745




Ordinary


Purchase


700


4758




Ordinary


Purchase


500


4756




Ordinary


Purchase


1,200


4755




Ordinary


Purchase


900


4757




Ordinary


Purchase


200


4779




Ordinary


Purchase


700


4749




Ordinary


Purchase


100


4750




Ordinary


Purchase


600


4783




Ordinary


Purchase


400


4782




Ordinary


Purchase


1,900


4782




Ordinary


Purchase


200


4778




Ordinary


Purchase


500


4752




Ordinary


Purchase


900


4750




Ordinary


Purchase


200


4771




Ordinary


Purchase


700


4772




Ordinary


Purchase


1,500


4773




Ordinary


Purchase


600


4774




Ordinary


Purchase


500


4773




Ordinary


Purchase


100


4773




Ordinary


Purchase


1,400


4770




Ordinary


Purchase


1,300


4750




Ordinary


Purchase


600


4775




Ordinary


Purchase


700


4745




Ordinary


Purchase


1,300


4759




Ordinary


Purchase


500


4777




Ordinary


Purchase


100


4779




Ordinary


Purchase


300


4739




Ordinary


Purchase


300


4746




Ordinary


Purchase


300


4754




Ordinary


Purchase


300


4765




Ordinary


Purchase


300


4734




Ordinary


Purchase


100


4769




Ordinary


Purchase


100


4777




Ordinary


Purchase


1,300


4734




Ordinary


Purchase


252,354


4725




Ordinary


Purchase


80


4725




Ordinary


Purchase


50


4700




Ordinary


Sale


1,000


4763




Ordinary


Sale


200


4765




Ordinary


Sale


500


4779




Ordinary


Sale


500


4769




Ordinary


Sale


400


4759




Ordinary


Sale


600


4752




Ordinary


Sale


800


4756




Ordinary


Sale


300


4749




Ordinary


Sale


1,000


4791




Ordinary


Sale


600


4750




Ordinary


Sale


1,000


4778




Ordinary


Sale


1,000


4777




Ordinary


Sale


1,000


4748




Ordinary


Sale


1,000


4754




Ordinary


Sale


1,000


4753




Ordinary


Sale


400


4755




Ordinary


Sale


2,000


4755




Ordinary


Sale


1,000


4752




Ordinary


Sale


400


4785




Ordinary


Sale


1,000


4749




Ordinary


Sale


500


4785




Ordinary


Sale


2,000


4749




Ordinary


Sale


1,000


4786




Ordinary


Sale


200


4789




Ordinary


Sale


200


4757




Ordinary


Sale


100


4747




Ordinary


Sale


100


4750




Ordinary


Sale


100


4754




Ordinary


Sale


1,100


4747




Ordinary


Sale


800


4753




Ordinary


Sale


1,200


4734




Ordinary


Sale


300


4758




Ordinary


Sale


1,100


4753




Ordinary


Sale


700


4751




Ordinary


Sale


1,200


4753




Ordinary


Sale


1,000


4756




Ordinary


Sale


500


4780




Ordinary


Sale


1,100


4747




Ordinary


Sale


12,900


4734




Ordinary


Sale


300


4760




Ordinary


Sale


200


4753




Ordinary


Sale


800


4751




Ordinary


Sale


100


4751




Ordinary


Sale


400


4749.5




Ordinary


Sale


400


4757




Ordinary


Sale


200


4786




Ordinary


Sale


41,950


4751.4398




Ordinary


Sale


83


4730








Total Purchases


314,284












Total Sales


86,233








 
 
(b)        Cash-settled derivative transactions
 




Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit JPY




Ordinary


CFD


Increasing a long position


41,950


4751.4398




 
 (c)       Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 




Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit JPY






































 
(ii)        Exercise
 




Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit JPY




















 
 




 
(d)        Other dealings (including subscribing for new securities)
 




Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable) JPY








 
 












4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 




Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
 
 




 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 




Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
 
 




 
(c)        Attachments
 




Is a Supplemental Form 8 (Open Positions) attached?


YES




 
 




Date of disclosure:


20/07/2018




Contact name:


Olivier Vero




Telephone number:


+44 20 7676 6969




 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
1.         KEY INFORMATION
 




Full name of person making disclosure:


SOCIETE GENERALE SA




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Takeda Pharmaceutical CO LTD




 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 
 




Class of relevant security


Product description e.g. call option


Written or purchased


Number of securities to which option or derivative relates


Exercise price per unit


Type


Expiry date




JPY


e.g. American, European etc.




Ordinary


OTC put-option


Sale


15,700


4707


European options


14/12/2018




Ordinary


OTC put-option


Sale


30,000


5075.10


European options


14/12/2018




Ordinary


OTC put-option


Sale


29,600


5073.65


European options


14/12/2018




Ordinary


OTC put-option


Sale


15,500


4491.40


European options


14/12/2018




Ordinary


OTC put-option


Sale


30,700


4533.90


European options


14/12/2018




 
 
 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 




Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 




 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
 
The currency of all prices and other monetary amounts should be stated.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETSEDSASFASEFW